Abstract:Graphic overview of the role of mitochondrial dysfunction in the pathogenesis of IVDD. An imbalance between ROS intercellular production and antioxidant defense capacity will directly give rise to the occurrence of oxidative stress, which is mainly represented by cell apoptosis, abnormal autophagy, cell senescence, and mitochondrial dysfunction. Among the oxidative stress‐related pathophysiological processes, mitochondrial dysfunction plays an essential role in the disc pathology of IVDD, which manifests as imbalanced dynamics and dysregulated mitophagy. ROS promotes the fusion of mitochondria, which decreases their fission process, so that disabled mitochondria can be separated from the mitochondrial pool. Further, mitophagy serves as the quality control mechanism, which can be dysregulated under the condition of oxidative stress by overwhelmingly clearing both dysfunctional and normal mitochondria. Overall, the effects of mitochondria dysfunction result in the massive disc cell death with overproduction of MMP and the degradation of ECM, eventually the pathogenesis of IVDD. Intervertebral disc degeneration (IVDD) is the most common contributor to low back pain (LBP). Recent studies have found that oxidative stress and reactive oxygen species (ROS) play an important role in IVDD. As a by‐product of aerobic respiration, ROS is mainly produced in the mitochondria by the electron transport chain and other mitochondrial located proteins. With the excessive accumulation of ROS, mitochondria are also the primary target of ROS attack in disc cells. A disrupted balance between intracellular ROS production and antioxidant capacity will lead to oxidative stress, which is the key contributor to cell apoptosis, cell senescence, excessive autophagy, and mitochondrial dysfunction. As the pivotal ingredient of oxidative stress, mitochondrial dysfunction manifests as imbalanced mitochondrial dynamics and dysregulated mitophagy. Mitochondria can alter their own dynamics through the process of fusion and fission, so that disabled mitochondria can be separated from the mitochondrial pool. Moreover, mitophagy participates by clearing these dysfunctional mitochondria. Abnormality in any of these processes either increases the production or decreases the clearance of ROS, leading to a vicious cycle that results in the death of intervertebral disc cells in large quantities, combined with degradation of the extracellular matrix and overproduction of matrix metalloproteinase. In this review, we explain the changes in mitochondrial morphology and function during oxidative stress‐mediated IVDD and highlight the important role of mitochondria in this process. Eventually, we summarize the IVDD therapeutic strategies targeting mitochondrial dysfunction based on current understanding of the role of oxidative stress in IVDD.

Role of Mitophagy in Intervertebral Disc Degeneration: A Narrative Review

Autophagy as a potential therapeutic target in intervertebral disc degeneration

Autophagy: A Double-Edged Sword in Intervertebral Disk Degeneration

Mitochondrial dysfunction: a new molecular mechanism of intervertebral disc degeneration

Altered metabolism driven by post-translational modifications in intervertebral disc degeneration

The Role of Mir-31-5p in the Development of Intervertebral Disc Degeneration and Its Therapeutic Potential.

Mitophagy in degenerative joint diseases

Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration

Mitochondrial Dysfunction in Oxidative Stress‐Mediated Intervertebral Disc Degeneration

Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration

Update on the Roles of Macrophages in the Degeneration and Repair Process of Intervertebral Discs.

Macrophages and Intervertebral Disc Degeneration

Molecular mechanisms of cell death in intervertebral disc degeneration (Review)

MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration

Roles of p38 MAPK signalling in intervertebral disc degeneration

The mitochondrial UPR induced by ATF5 attenuates intervertebral disc degeneration via cooperating with mitophagy

Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy

Unraveling the mechanisms of intervertebral disc degeneration: an exploration of the p38 MAPK signaling pathway

Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration

Pathogenesis and therapeutic implications of matrix metalloproteinases in intervertebral disc degeneration: A comprehensive review

Glycine-Serine-Threonine Metabolic Axis Delays Intervertebral Disc Degeneration Through Antioxidant Effects: an Imaging and Metabonomics Study